Chemical, biochemical, and medicinal properties of the diphosphonates

The Role of Phosphonates in Living Systems

Volumn , Issue , 2018, Pages 55-96

  Francis, Marion D ^a   Martodam, Raymond R ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85054199355     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781351076470     Document Type: Chapter

References (249)

1. Harvey, R. G. and DeSombre, E. R., The Michaelis-Arbuzov and related reactions, Top. Phosphorus Chem., 1, 57, 1964.
2. Canavan, A. E., Dowden, B. F., and Eaborn, C, The thermal decomposition of alkylphosphonates: a new route to alkylphosphonic acids, J. Chem. Soc, 331, 1962.
3. Curry, J. D. and Nicholson, D. A., Oligophosphonates, Top. Phosphorus Chem., 7, 37, 1972.
4. Von Blaser, B., Worms, K.-H., Germscheid, H.-G., and Wollmann, K., Uber l-hydroxyalkan-1,1-diphosphonsaiiren, Z. Anorg. Allg. Chem., 381, 247, 1971.
5. Sekine, M. and Hata, T., Convenient synthesis of unesterified acylphosphonic acids, J. Chem. Soc, Chem. Commun., 285, 1978.
6. Worms, K.-H. and Blum, H., Unsetzungen von 1-aminoalkan-1,1-diphosphonsaiiren mil saltpetriger satire, Z. Anorg. Allg. Chem., 457, 209, 1979.
7. Kosolapoff, G. M. and Maier, L., Organic Phosphorus Compounds, Vol. 7, John Wiley & Sons, New York, 1976, chap. 18.
8. Schroeder, J. P. and Sopchak, W. P., The reaction of phosphorus trichloride and oxygen with polymers, J. Polym. Sci., Al 47, 417, 1960.
9. Rochlitz, F. and Vilcsek, H., B-Chloroethylphosphonic dichloride: its synthesis and use, Angew. Chem., Int. Ed., 74, 940, 1962.
10. Anbar, M., St. John, G. A., and Scott, A. C., Organic polymeric polyphosphonates as potential preventive agents of dental caries: in vitro experiments, J. Dent. Res., 53, 867, 1974.
11. Cabasso, I., Jagur-Grodzinski, J., and Vofsi, D., Synthesis and characterization of polymers with pendant phosphonate groups, J. Appl. Polym. Sci., 18, 1969, 1974.
12. Bartels, T., Schuthof, J., and Ahrends, J., The adsorption of two polyphosphonates on hydroxyapatite and their influence on the acid solubility of whole bovine enamel, J. Dent., 7, 221, 1979.
13. Anbar, M., St. John, G. A., and Edward, T. E., Organic polymeric polyphosphonates as potential preventive agents of dental caries. In vivo experiments, J. Dent. Res., 53, 1240, 1974.
14. Francis, M. D. and Briner, W. W., The effect of phosphonates on dental enamel in vitro and calculus formation in vivo, Calcif. Tissue Res., 11, 1, 1973.
15. Briner, W. W. and Francis, M. D., In vitro and in vivo evaluation of anti-calculus agents, Calcif. Tissue Res., 11, 10, 1973.
16. Meyer, J. L. and Nancollas, G. H., The influence of multidentate organic phosphonates on the crystal growth of hydroxyapatite, Calcif. Tissue Res., 13, 295, 1973.
17. Kabachnik, M. I., Lastovskii, R. P., Medvad, T. Y., Medyntser, V. V., Kolpakova, I. I., and Dyatlova, N. M., The complexing properties of hydroxyethylidenediphosphonic acid in aqueous solutions, Dokl. Akad. Nauk., SSSR, 177, 582, 1967.
18. Grabenstetter, R. J., Quimby, O. T., and Flaut, T. J., The acid dissociation constants of substituted methanediphosphonic acids: a correlation with P31 magnetic resonance chemical shift and with Taft a, J. Phys. Chem., 71, 4194, 1967.
19. Carroll, R. L. and Irani, R. R., On the acidity of substituted methylenediphosphonates and their interaction with alkali metal ions, Inorg. Chem., 6, 1994, 1967.
20. Francis, M. D. and Centner, R. L., The development of diphosphonates as significant health care products, J. Chem. Ed., 55, 760, 1978.
21. Tobias, R. S., Studies on the hydrolysis of metal ions. 21. The hydrolysis of tin (II) ion, Sn2 +, Acta Chem. Scand., 12, 198, 1958.
22. Grabenstetter, R. J. and Cilley, W. A., Polynuclear complex formation in solutions of calcium ion and ethane-1-hydroxy-1,1-diphosphonic acid. 1. Complexometric and pH titrations, J. Phys. Chem., 75, 676, 1971.
23. Wiers, B. H., Polynuclear complex formation in solution of calcium ion and ethane-1-hydroxy-1,1-di-phosphonic acid. II. Light scattering, sedimentation, mobility and dialysis measurements, J. Phys. Chem., 75, 682, 1971.
24. Yesinowski, J. P. and Benedict, J. J., Unpublished work, 1978.
25. Oeutsch, E. and Barnett, B. L., Synthetic and structural aspects of technetium chemistry as related to nuclear medicine, in ACS Symposium Series, No. 140, Inorganic Chemistry in Biology and Medicine, Martell, A. E., Ed., American Chemical Society, Washington, DC, 1980, 103.
26. Barnett, B. L. and Strickland, L. C, Structure of disodium dihydrogen 1-hydroxyethylidenediphosphonate tetrahydrate: a bone growth regulator, Acta Crystallogr., B35, 1212, 1979.
27. Francis, M. D., Tofe, A. J., Benedict, J. J., and Bevan, J. A., Imaging the skeletal system, in Radiopharmaceuticals II, Proc. 2nd Int. Symp. on Radiopharm., Society of Nuclear Medicine, New York, 1979, 603.
28. Bevan, J. A., Tofe, A. J., Francis, M. D., Barnett, B. L., and Benedict, J. J., Tc-99m HMDP (hydroxymethylenediphosphonate): a new radiopharmaceutical for skeletal and acute myocardial infarct imaging. Part I. Synthesis and biodistribution in animals. Part II. Comparison of Tc-99m HMDP with other technetium labelled bone imaging agents in a canine model, J. Nucl. Med., 21, 961, 1980.
29. Francis, M. D., The inhibition of calcium hydroxyapatite crystal growth by polyphosphonates and polyphosphates, Calcif. Tissue Res., 3, 151, 1969.
30. Francis, M. D. and Webb, N. C, Hydroxyapatite formation from a hydrated calcium monohydrogen phosphate precursor, Calcif. Tissue Res., 6, 335, 1971.
31. Francis, M. D., Composition for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue, U.S. Patent 3,683,080, 1972.
32. Francis, M. D., Russell, R. G. G., and Fleisch, H., Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo, Science, 165, 1264, 1969.
33. Francis, M. D., Slough, C. L., Briner, W. W., and Oertel, R. P., An investigation of melitate and ethane-1-hydroxy-1,1-diphosphonate in calcium phosphate systems, Calcif. Tissue Res., 23, 53, 1977.
34. Sturzenburger, O. P., Swancar, J. R., and Reiter, G., Reduction of dental calculus in humans through the use of a dentrifice containing a crystal-growth inhibitor, J. Periodont., 42, 416, 1971.
35. Conroy, C. W., Sturzenburger, O. P., Bollmer, B. W., Swancar, J. R., and Zimmerman, E. R., The effect of a sodium etidronate dentifrice on calculus and gingivitis in adults, J. Dent. Res., (Suppl. 208), 100, 1972.
36. Herforth, V. A., Fligge, U., and Strossburg, M., Clinical investigation on the reduction of calculus formation by use of a toothpaste containing 1% HEDP, Dtsch. Zahnaertztl. Z., 32, 757, 1977.
37. Stover, S. L., Hahn, H. R., and Miller, J. M., Disodium etidronate in the prevention of heterotopic ossification following spinal cord injury, Paraplegia, 14, 146, 1976.
38. Finerman, G. A. M., Krenzel, W. F., Jr., Lowell, J. D., Murray, W. R., Volz, R. G., Bowerman, J. W., and Gold, R. H., Role of diphosphonate (EHDP) in the prevention of heterotopic ossification after total hip arthroplasty, in The Hip Proceedings, Vol. 5, Open Scientific Meeting of the Hip Society, C. V. Mosby, St. Louis, 1977, 222.
39. Bijvoet, O. L. M., Nollen, A. J. G., Slooff, T. J. J. H., and Feith, R., Effect of a diphosphonate on para-articular ossification after total hip replacement, Acta Orthop. Stand., 45, 926, 1974.
40. Nixon, G. A., Buehler, E. V., and Newman, E. A., Preliminary safety assessment of disodium etidronate as an additive to experimental oral hygiene products, Toxicol. Appl. Pharmacol., 22, 661, 1972.
41. Tofe, A. J. and Francis, M. D., The author’s reply, J. Nucl. Med., 16, 444, 1975.
42. Francis, M. D. and Slough, C. L., Acute IV infusion of etidronate disodium(EHDP): mechanism of toxicity, Acad. Pharm. Sci., Abstr. 5, 1981.
43. Francis, M. D. and Slough, C. L., Unpublished work, 1975.
44. King, W. R., Francis, M. D., and Michael, W. R., Effect of disodium ethane-1-hydroxy-1,1-diphosphonate on bone formation, Clin. Orthop., 78, 251, 1971.
45. Nolen, G. A. and Buehler, E. V., The effects of disodium etidronate on the reproductive functions and embryogeny of albino rats and New Zealand rabbits, Toxicol. Appl. Pharmacol., 18, 548, 1971.
46. Nixon, G. A. and Buehler, E. V., Unpublished work, 1972.
47. Flora, L., Hassing, G. S., Parfitt, A. M., and Villanueva, A. R., Comparative skeletal effects of two diphosphonates in dogs, in Bone Histomorphometry, Jee, W. S. S. and Parfitt, A. M., Eds., Societe de Publications Medicales et Dentaires, Paris, 1981, 389.
48. Flora, L., Unpublished work, 1980.
49. Vignery, A. and Baron, R., Comparative effects of APD and C12MDP on bone in the rat: in vivo and in vitro studies, in Bone Hislomorphology, Jee, W. S. S. and Parfitt, A. M., Eds., Societe de Publications Medicales at Dentaires, Paris, 1981, 381.
50. Michael, W. R., King, W. R., and Wakim, J. M., Metabolism of disodium ethane-1 -hydroxy-1,1 -diphosphonate (disodium etidronate) in the rat, rabbit, dog, and monkey, Toxicol. Appl. Pharmacol., 21, 503, 1972.
51. Saville, P. D. and Recker, R. R., Unpublished work, 1973.
52. Michael, W. R., Unpublished work, 1970.
53. Varus, C. L., Harvey, W. J., and King, W. R., Unpublished work. 1974.
54. Ginn, D. L. and Hedglin, W. L., Unpublished work, 1974.
55. Hedglin, W. L. and Ginn, D. L., Unpublished work, 1974.
56. King, W. R., Unpublished work, 1974.
57. Wasserman, R. H., Bonjour, J. P., and Fleisch, H., Ileal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) and disodium dichloromethylene diphosphonate (C12MDP) in the chick, Experientia, 29, 1110, 1973.
58. Liggett, J. S., Unpublished work, 1974.
59. Wellman, H. N., Browne, A., Kavula, M., Khairi, R., Anger, R., Tofe, A. J., and Francis, M. D., Optimization of a new kit - prepared skeletal imaging agent, 9gmTc-Sn-EHDP, compared with lsF, in Radiopharmaceuticals and Labeled Compounds, International Atomic Energy Agency, Vienna, 1973, 1.
60. Silberstein, E., Saenger, E., Tofe, A., Alexander, G., and Park, H., Imaging of bone metastases with Tc-Sn-EHDP (diphosphonate), F, and skeletal radiography - a comparison of sensitivity, Radiology, 197, 551, 1973.
61. Troehler, U., Bonjour, J. P., and Fleisch, H., Renal secretion of diphosphonates in rats, Kidney Int., 8, 6, 1975.
62. La Nauze, J. M., Rosenberg, H., and Shaw, D. C, The enzymatic cleavage of the carbon-phosphorus bond, purification and properties of the phosphonatase, Biochim. Biophys. Acta, 212, 332, 1970.
63. Floyd, B., Francis, S., and Benedict, J. J., Unpublished work, 1978.
64. Preston, D., Dittert, L. W., and Foster, T., Unpublished work, 1973.
65. Reynolds, J. J., Minkin, C, Morgan, D. B., Spychen, D., and Fleisch, H., The effects of two diphosphonates on the resorption of mouse calvaria in vitro, Calcif. Tissue Res., 10, 302, 1972.
66. Russell, R. G. G., Muhlbauer, R. C., Bisaz, S., Williams, D. A., and Fleisch, H., The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomized rats, Calcif. Tissue Res., 6, 183, 1970.
67. Fleisch, H., Russell, R. G. G., and Francis, M. D., Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo, Science, 165, 1262, 1969.
68. Hausman, E., Weinfeld, N., and Michaels, S., Lipopolysaccharide-diphosphonate interaction on bone in tissue culture, Arch. Oral Biol., 17, 1381, 1972.
69. Goldberg, L. S., Unpublished work, 1979.
70. Gebauer, U. and Fleisch, H., The effects of two diphosphonates on the resorption of mouse calvaria induced by 1,25-dihydroxy-cholecalciferol and prostaglandin E, in culture, Miner. Electrolyte Metab., 4, 172, 1980.
71. Rowe, D. J. and Hausman, E., The alteration of osteoclast morphology by diphosphonates in bone organ culture, Calcif. Tissue Res., 20, 53, 1976.
72. Schenk, R., Merz, W. A., Muhlbauer, R., Russell, R. G. G., and Fleisch, H., Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (C12MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats, Calcif. Tissue Res. ,11, 196, 1973.
73. Miller, S. C. and Jee, W. S. S., Ethane-1-hydroxy-1,1-diphosphonate (EHDP): Effects on growth and modeling of the rat tibia Calcif. Tissue Res., 18, 215, 1975.
74. Miller, S. C., Jee, W. S. S., Kimmel, D. B., and Woodbury, L., Ethane-1-hydroxy-1,1-diphosphonate (EHDP) effects on incorporation and accumulation of osteoclast nuclei, Calcif. Tissue Res., 22, 243, 1977.
75. Plasmans, C. M. T., Jap, P. H. K., Kuijpers, W., and Slooff, T. J. J. H., Influence of a diphosphonate on the cellular aspect of young bone tissue, Calcif. Tissue Int., 32, 247, 1980.
76. Rosenblum, I. Y., McCuskey, R. S., McNeal, N. C., Kirckaert, G. A., Flora, L., and Metzger, C. A., The effects of EHDP on regenerating trabecular bone using in vivo microscopic, light and electron microscopic and electron microprobe techniques, Calcif. Tissue Res., 20, 91, 1976.
77. Plasmans, C. M. T., Kuijpers, W., and Slooff, T. J. J. H., The effect of ethane-1-hydroxy-1,1-diphosphonic acid (EHDP) on matrix induced ectopic bone formation, Clin. Orthop., 132, 233, 1978.
78. Weisbrode, S. E., Capen, C. C., and Pendley, C. B., Effect of dichloromethylene diphosphonate on morphology, enzyme activity, and ash content of bones of thyroparathyroidectomized rats, Calcif. Tissue Res., 25, 119, 1978.
79. Ende, J. J., Some effects of EHDP and C12MDP on the metabolism of isolated bone cells, Proc. K. Ned. Akad. Wet. Ser. C. Biol. Med. Sci., 81, 252, 1978.
80. Fast, D. K., Felix, R., Dowse, C., Neuman, W. F., and Fleisch, H., The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture, Biochem. J., 172, 97, 1978.
81. Felix, R., Fast, D. K., Sallis, J. D., and Fleisch, H., Effects of diphosphonates on glycogen content of rabbit ear cartilage cells in culture, Calcif. Tissue Int., 30, 163, 1980.
82. Morgan, D. B., Monod, A., Russell, R. G. G., and Fleisch, H., Influence of dichloromethylene diphosphonate (C12MDP) and calcitonin on bone resorption, lactate production and phosphatase and pyrophosphatase content of mouse calvaria treated with parathyroid hormone in vitro, Calcif. Tissue Res., 13, 287, 1973.
83. Ende, J. J. and van Rooijen, H. J. M., Some effects of EHDP and C12MDP on the metabolism of mouse calvaria in tissue culture, Proc. K. Ned. Akad. Wet. Ser. C. Biol. Med. Sci., 82, 43, 1979.
84. Shinoda, H., Felix, R., and Fleisch, H., Structure-activity relationship of diphosphonates with alkyl groups of various length, Miner. Electrolyte Metab., 2, 268, 1979.
85. Lemkes, H. H. P. J., Reitsma, P. H., Frijlink, W., Verlinden-Ooms, H., and Bijvoet, O. L. M., A new diphosphonate: dissociation between effects on cells and mineral in rats and a preliminary trial in Paget’s disease, Adv. Exp. Med. Biol, 103, 459, 1978.
86. Pilczyk, R., Sutcliffe, H., and Martin, T. L., Effects of pyrophosphate and diphosphonates on parathyroid hormone-and fluoride-stimulated adenylate cyclase activity, FEBS Lett., 24, 225, 1972.
87. Eisman, J. A., Martin, T. J., Pilczyk, R., Legge, D. G., and Sutcliffe, H. S., Influence of pyrophosphate and diphosphonates on rat liver adenylate cyclase, Clin. Exp. Pharmacol Physiol, 1, 13, 1974.
88. Goulding, A., McChesney, R., and Malthus, R. S., Diminished urinary excretion of cyclic AMP by rats given disodium ethane-l-hydroxy-l,l-diphosphonate, J. Endocrinol, 65, 145, 1975.
89. Gebauer, U., Russell, R. G. G., Touabi, M., and Fleisch, H., Effect of diphosphonates on adenosine 3':5‘cyclic monophosphate in mouse calvaria after stimulation by parathyroid hormone in vitro, Clin. Sci. Mol Med., 50, 473, 1976.
90. Felix, R., Russell, R. G. G., and Fleisch, H., The effect of several diphosphonates on acid phosphoh-ydrolases and other lysosomal enzymes, Biochem. Biophys. Acta, 429, 429, 1976.
91. Guilland, D. E., Sallis, J. D., and Fleisch, H., The effect of two diphosphonates on the handling of calcium by rat kidney mitochondria in vitro, Calcif. Tissue Res., 15, 303, 1974.
92. Guilland, D. F. and Fleisch, H., The effect of in vivo treatment with EHDP and/or 1,25-DHCC on calcium uptake and release in isolated kidney mitochondria, Biochem. Biophys. Res. Commun., 61, 906, 1974.
93. Felix, R. and Fleisch, H., The effects of pyrophosphate and diphosphonates on calcium transport in red cells, Separatum Experientia, 33, 1003, 1977.
94. Felix, R. and Fleisch, H., Increase in alkaline phosphatase activity in calvaria cells cultured with diphosphonates, Biochem. J., 183, 73, 1979.
95. Weisbrode, S. E., Capen, C. C, and Pendley, C. B. II, Interaction of dichloromethylene diphosphonate and vitamin D on bone of thyroparathyroidectomized rats, Am. J. Pathol., 89, 137, 1977.
96. Felix, R., Herrmann, W., and Fleisch, H., Stimulation of precipitation of calcium phosphate by matrix vesicles, Biochem. J., 170, 681, 1978.
97. Woltgens, J. H. M., Bervoets, T. H. J. M., and DeVries, W., Influence of diphosphonates on the pyrophosphatase activity in Streptococcus mutans, J. Periodontal Res., 12, 462, 1977.
98. Herczog, J. I. B., DeVries, W., and Woltgens, J. H. M., Influence of ethane-1-hydroxy-1,1-diphosphonate on anaerobic growth and acid formation by S. mutans, Caries Res., 11, 90, 1977.
99. Vreven, J. and Frank, R. M., Activities pyrophosphatiques acide et alcaline de la plaque dentaire humaine, Arch. Oral. Biol., 19, 203, 1974.
100. Ritz, H. L., Microbial populationship in developing human dental plaque, Arch. Oral. Biol., 12, 1561, 1967.
101. Guenther, H. L., Guenther, H. E., and Fleisch, H., Effects of 1-hydroxyethane-1,1-diphosphonate and dichloromethanediphosphonate on rabbit articular chondrocytes in culture, Biochem. J., 184, 203, 1979.
102. Palmoski, M. and Brandt, K., Effects of diphosphonates on glycosaminoglycan synthesis and proteoglycan aggreagation in normal adult articular cartilage, Arthritis Rheum., 21, 942, 1978.
103. Spengler, D. M., Baylink, D. J., Rosenquist, J. B., and Evans, R., Mechanical properties of connective tissue: effect of diphosphonate, Clin. Res., 25, 368A, 1977.
104. Guenther, H. L., Guenther, H. E., Fast, D. K., and Fleisch, H., The effect of two diphosphonates on the collagen metabolism of mouse and rat bone and cartilage, Experientia, 3, 792, 1977.
105. Miller, S. C. and Jee, W. S. S., The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat, Anat. Rec, 193, 439, 1979.
106. Miller, S. C. and Jee, W. S. S., The comparative effects of dichloromethylene diphosphonate (C12MDP) and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibia, Calcif. Tissue Res., 23, 207, 1977.
107. Larsson, A. and Larsson, S. E., The effects of ethane-1-hydroxy-1,1-diphosphonate on cellular transformation and organic matrix of the epiphyseal growth plate of the rat: a light microscopic and ultrastructural study, Acta Pathol. Microbiol. Scand., 86, 211, 1978.
108. Russell, J. E., Termine, J. D., and Avioli, L. V., Experimental renal osteodystrophy. The response to 25-hydroxycholecalciferol and dichloromethylene diphosphate therapy, J. Clin. Invest., 56, 548, 1975.
109. Reynolds, J. J., Murphy, H., Miihlbauer, R. C., Morgan, D. B., and Fleisch, H., Inhibition by diphosphonates of bone resorption in mice and comparison with grey lethal osteopetrosis, Calcif. Tissue Res., 12, 59, 1973.
110. Yarrington, J. T., Capen, C. C, Black, H. E., Potts, J. T., Jr., and Geho, W. B., Experimental parturient hypocalcemia in cows following prepartal chemical inhibition of bone resorption, Am. J. Pathol., 83, 569, 1976.
111. Yarrington, J. T., Capen, C. C, Black, H. E., Nagode, L. A., and Geho, W. B., Effect of dichlo-romethane diphosphonate on calcium homeostasis mechanisms in pregnant cows, Am. J. Pathol., 87, 615, 1977.
112. Bonjour, J. P., Fleisch, H., and Copp, D. H., Influence of a diphosphonate on serum calcium homeostasis, Proc. Exp. Biol. Med., 143, 404, 1973.
113. Yarrington, J. T., Capen, C. C, Black, H. E., Potts, J. T., Jr., and Geho, W. B., Effect of ethane-1 -hydroxy-1,1 -diphosphonate (EHDP) on the ultrastructure of parathyroid glands and plasma immunoreac-tive parathyroid hormone in pregnant cows fed a low calcium diet, Lab. Invest., 36, 402, 1977.
114. Michael, W. R., King, W. R., and Francis, M. D., Effectiveness of diphosphonates in preventing “osteoporosis” of disuse in the rat, Clin. Orthop. Relat. Res., 78, 271, 1971.
115. Miihlbauer, R. C, Russell, R. G. G., Williams, D. A., and Fleisch, H., The effects of diphosphonates, polyphosphates, and calcitonin on “immobilisation osteoporosis” in rats, Eur. J. Clin. Invest., 1, 336, 1971.
116. Goulding, A. and McChesney, R., Comparison of effects of parathyroidectomy and ethane-1-hydroxy-1,1-diphosphonate (EHDP) administration upon bone synthesis of hydroxyproline and urinary excretion of hydroxyproline in rats, Calcif. Tissue Res., 23, 115, 1977.
117. Fleisch, H., Russell, R. G. G., Simpson, B., and Miihlbauer, R. C, Prevention by a diphosphonate of immobilization “osteoporosis” in rats, Nature (London), 223, 211, 1969.
118. Lane, J. M. and Steinberg, M. E., The role of diphosphonates in osteoporosis of disuse, J. Trauma, 13, 863, 1973.
119. Cabanela, M. E. and Jowsey, J., The effects of phosphonates on experimental osteoporosis, Calcif. Tissue Res., 8, 114, 1971.
120. Cates, J., Sheets, D. D., and Johnston, C. C, Jr., Prevention of disuse osteoporosis in the rat, Clin. Res., 19, 473, 1971.
121. Ellsasser, J. C, Moyer, C. F., Lesker, P. A., and Simmons, D. J., Effect of low doses of disodium ethane-1-hydroxy-1,1-diphosphonate on disuse osteoporosis in the denervated cat tail, Clin. Orthop. Relat. Res., 91, 235, 1973.
122. Black, H. E. and Jee, W. S. S., A histomorphometric and biochemical evaluation of the effects of a diphosphonate in corticosteroid-treated rabbits, in Bone Histomorphometry, P. J. Meunier, Ed., Armour Montagu, Paris, 1977, 157.
123. Hahnel, H., Muhlbach, R., Lindenhayn, K., Schaetz, P., and Schmidt, U. J., Zum Einfluss von Diphosphonat auf die experimentelle Heparinosteopathie, Z. Alternsforsch., 27, 289, 1973.
124. Hahnel, H. Lindenhayn, K., Muhlbach, R., Schmidt, U. J., and Kalbe, I., Antikoagulantienosteopathie durch Kumarin und deren Beeinfluseng mit Diphosphonat. Eine tierexperimentelle Studie, Dtsch. Gesun-dheitswes., 31, 856, 1976.
125. Kaye, M., The effect of a diphosphonate on uremic hyperparathyroidism, Nephron, 10, 188, 1973.
126. Jowsey, J. and Holley, K. E., Influence of diphosphonates on progress of experimentally induced osteoporosis, J. Lab. Clin. Med., 82, 567, 1973.
127. Morgan, D. B., Gasser, A., Largiader, U., Jung, A., and Fleisch, H., Effects of a diphosphonate on calcium metabolism in calcium-deprived rats, Am. J. Physiol., 228, 1750, 1975.
128. Lindenhayn, K., Schmidt, U. J., Hirthe, D., Wegner, G., and Kalbe, I., Zur Wirkung von Dexa-methason und Diphosphonat auf den Knochen, Dtsch. Gesundheitswes., 28, 202, 1973.
129. Gasser, A. B., Morgan, D. B., Fleisch, H. A., and Richelle, L. J., The influence of two diphosphonates on calcium metabolism in rat, Clin. Sci., 43, 31, 1972.
130. Weisbrode, S. E., Capen, C. C, and Pendley, C. B., Effect of dichloromethylene diphosphonate on morphology, enzyme activity, and ash content of bones of thyroparathyroidectomized rats, Calcif. Tissue Res., 25, 119, 1978.
131. Flora, L., Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis, Arthritis Rheum., 22, 340, 1979.
132. Francis, M. D., Flora, L., and King, W. R., The effects of disodium ethane-1 -hydroxy-1,1 -diphosphonate on adjuvant induced arthritis in rats, Calcif. Tissue Res., 9, 109, 1972.
133. Baker, B. L. and Ebert, M., Unpublished work, 1981.
134. Komissarenko, S. V., Zhuravskii, N. I., Karlova, N. P., and Gulyi, M. F., Inhibition of hypersensitivity of delayed and immediate types in guinea pigs by methylenediphosphonic acid, Bull. Exp. Biol. Med., 84, 1322, 1977.
135. Galasko, C. S. B., Mechanism of bone destruction in the development of skeletal matastases, Nature (London), 263, 507, 1976.
136. Chopra, D. and Clerkin, E. P., Hypercalcemia and malignant disease, Med. Clin. N. Am., 59, 441, 1975.
137. Besarab, A. and Caro, J. F., Mechanisms of hypercalcemia in malignancy, Cancer, 41, 2276, 1978.
138. Gordan, G. S., Osteolytic sterol in human breast cancer, Science, 151, 1226, 1966.
139. Mundy, G. R., Evidence for the secretion of an osteoclast stimulating factor in myeloma, N. Engl. J. Med., 291, 1041, 1974.
140. Voelkel, E. F., Tashjian, A. H., Jr., Franklin, R., Wasserman, E., and Levine, L., Hypercalcemia and tumor prostaglandins: the VX2, carcinoma in the rabbit, Metab. Clin. Exp., 24, 973, 1975.
141. Wolfe, H. J., Bitman, W. R., Voelkel, E. F., Griffiths, H. J., and Tashjian, A. H., Systemic effects of the VX2, carcinoma on the osseous skeleton: a quantitative study of trabecular bone, Lab. Invest., 38, 208, 1978.
142. Doppelt, S., Slovik, D., Neer, R., and Potts, J., Dichloromethane diphosphonate treatment of hypercalcemia in the VX2 carcinoma bearing rabbit, in VII Int. Conf. on Calcium Regulating Hormones, Talmalge, R. V., Matthews, J. L., and Cohn, D., Eds., 1980, 165.
143. Minne, H., Streibl, W., Staneslaus, S., and Arnaud, C. D., Paraneoplastic parathyroid hormone secretion by the transplantable Walker carcinosarcoma 256 of the rat, Acta Endocrinol. Suppl., 215, 129, 1978.
144. Minne, H., Raue, F., Klar, H., Ziegler, R., and Bijvoet, O. L. M., Treatment of paraneoplastic hypercalcemia with a new diphosphonate (APD) in the animal experiment, in Symposium CEMO III, Bones andTumors, Donath, A. and Courvoisier, B., Eds., Editions Medecine et Hygiene, Geneva, 1980, 166.
145. Jung, A., Bornand, J., van Ouwenaller, C, Depierr, I., Chantraine, A., Donath, A., Seematte, R., and Courvoisier, B., Effect of diphosphonate on tumour-induced osteolysis in animals and in humans, in Symposium CEMO III, Bone and Tumors, Donath, A. and Courvoisier, B., Eds., Editions Medecine et Hygiene, Geneva, 1980, 170.
146. Jung, A., Barras, C, Mermillod, B., and Courvoisier, B., The effect of two diphosphonates on osteolysis induced by tumor extracts, Schweiz. Med. Wochenschr., 109, 1888, 1979.
147. Galasko, C. S. B., Samuel, A. W., Rushton, S., and Lacey, E., The effects of prostaglandin synthesis inhibitors and diphosphonates on tumor mediated osteolysis, Br. J. Surg., 67, 493, 1980.
148. Eilon, G. and Mundy, G. R., Direct resorption of bone by human breast cancer cells in vitro, Nature (London), 276, 726, 1978.
149. Martodam, R. R., Unpublished work, 1981.
150. Anderson, H. C., Matrix vesicles of cartilage and bone, in The Biochemistry and Physiology of Bone, Vol. IV, Bourne, G. H., Ed., Academic Press, New York, 1976, 135.
151. Felix, R., Herrmann, W., and Fleisch, H., Stimulation of precipitation of calcium phosphate by matrix vesicles, Biochem. J., 170, 681, 1978.
152. Boskey, A. L., Goldberg, M. R., and Posner, A. S., Effect of diphosphonates on hydroxyapatite formation induced by calcium-phospholipid-phosphate complexes, Calcif. Tissue Int., 27, 83, 1979.
153. Minkin, C., Rabadjija, L., and Goldhaber, P., Bone remodeling in vitro: the effects of two diphosphonates on osteoid synthesis and bone resorption in mouse calvaria, Calcif. Tissue Res., 14, 161, 1978.
154. King, W. R., Francis, M. D., and Michael, W. R., Effect of disodium ethane-1-hydroxy-1,1-diphosphonate on bone formation, Clin. Orthop. Relax. Res., 78, 251, 1971.
155. Russell, R. G. G., Kislig, A. M., Casey, P. A., Fleisch, H., Thornton, J., Schenk, R., and Williams, D. A., Effect of diphosphonates on calcitonin on the chemistry and quantitative histology of rat bone, Calcif. Tissue Res., 11, 179, 1973.
156. Rosenblum, I. Y., The effects of disodium ethane-1 -hydroxy-1,1 -diphosphonate (EHDP) on bone and serum chemistry in rabbits, Calcif. Tissue Res., 16, 145, 1974.
157. Larsson, A. and Larsson, S. E., Light microscopic and ultrastructural observations on the short term effects of ethylene-1-hydroxy-1,1-diphosphonate (EHDP) on rat tibia epiphysis, Acta Pathol. Microbiol. Scand., 84, 17, 1976.
158. Reitsma, P. H., Bijvoet, O. L. M., Verlinden-Ooms, H., and van der Wee-Pals, L. J. A., Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxy-propylidene)-1,1-bis-phosphonate (APD) in rats, Calcif. Tissue Int., 32, 145, 1980.
159. Evans, R. A., Baylink, D. J., and Wergedal, J., The effects of two diphosphonates on bone metabolism in the rat, Metab. Bone Dis. Relat. Res., 2, 39, 1979.
160. Howell, D. S., Muniz, O. E., Blanco, L. N., and Pita, J. C, A micropuncture study of growth cartilage in phosphonate (EHDP) induced rickets, Calcif. Tissue Int., 30, 35, 1980.
161. Potokar, M. and Schmidt-Dunker, M., The inhibitory effect of new diphosphonic acids on aortic and kidney calcification in vivo, Atherosclerosis, 30, 313, 1978.
162. Fleisch, H., Russell, R. G. G., Bisaz, S., Casey, P. A., and Miihlbauer, R. C, The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution of calcium phosphate in vitro and in vivo, Calcif. Tissue Res., 2(SuppI.), 10, 1968.
163. Fleisch, H. A., Russell, R. G. G., Bisaz, S., Miihlbauer, R. C, and Williams, D. A., The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo, Eur. J. Clin. Invest., 1, 12, 1970.
164. O’hara, J., Jowsey, J., and Williams, G. A., Effects of dichloromethylene diphosphonate, ethane-1-hydroxy-1,1-diphosphonate, and rickets in rats, J. Lab. Clin. Med., 86, 793, 1975.
165. Rosenblum, I. Y., Black, H. E., and Ferrell, J. F., The effects of various diphosphonates on a rat model of cardiac calciphylaxis, Calcif. Tissue Res., 23, 151, 1977.
166. Rosenblum, I. Y., Flora, L., and Eisenstein, R., The effects of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of atherosclerosis, Atherosclerosis, 22, 411, 1975.
167. Plasmans, C. M. T., Kuypers, W., and Slooff, T. J. J. H., The effect of ethane-1-hydroxy-1,1-diphosphonic acid (EHDP) on matrix induced ectopic bone formation, Clin. Orthop. Relat. Res., 132, 233, 1978.
168. Strates, B. S., Firschein, H. E., and Urist, M. R., Alkaline phosphatase and failure of calcification under the influence of a diphosphonate, Biochim. Biophys. Acta, 224, 121, 1971.
169. Fraser, D., Russell, R. G. G., Pohler, O., Robertson, W. G., and Fleisch, H., The influence of disodium ethane-1 -hydroxy-1,1 -diphosphonate (EHDP) on the development of experimentally induced urinary stones in rats, Clin. Sci., 42, 197, 1972.
170. Francis, M. I. Slough, C. L., Black, H. E., Tofe, A. J. and Cloyd, G. G., Diphosphonate treatment of a primary osteogenic sarcoma in a dog; a case report, Vet. Radiol., 21, 168, 1980.
171. Francis, M. D. and Slough, C. L., Unpublished work, 1975.
172. Gasser, A. B., Morgan, D. B., Fleisch, H. A., and Richelle, L. J., The influence of two diphosphonates on calcium metabolism in the rat, Clin. Sci., 43, 31, 1972.
173. Guilland, D., Trechsel, U., Bonjour, J, P., and Fleisch, H., Stimulation of calcium absorption and apparent increased intestinal 1,25 dihydroxycholecalciferol in rats treated with low doses of ethane-1-hydroxy-i.,1 -diphosphonate, Clin. Sci. Mol. Med., 48, 157, 1975.
174. Bonjour, J. P., Russell, R. G. G., Morgan, D. B., and Fleisch, H. A., Intestinal calcium absorption, Ca-binding protein, and Ca-ATPase in diphosphonate-treated rats, Am. J. Physiol., 224, 1011, 1973.
175. Bonjour, J. P., DeLuca, H. F., Fleisch, H., Trechsel, U., Matejowec, L. A., and Omdahl, J. L., Reversal of the EHDP inhibition of calcium absorption by 1,25-dihyroxycholecalciferol., Eur. J. Clin. Invest., 3, 44, 1973.
176. Baxter, L. A., DeLuca, H. F., Bonjour, J. P., and Fleisch, H., Inhibition of vitamin D metabolism by ethane-l-hydroxy-l,l-diphosphonate, Arch. Biochem. Biophys., 164, 655, 1974.
177. Hill, L. F., Lumb, G. A., Mawer, E. B., and Stanbury, S. W., Indirect inhibition of the biosynthesis of 1,25-dihydroxycholecalciferol in rats treated with a diphosphonate, Clin. Sci., 44, 335, 1973.
178. Trechsel, U., Bonjour, J. P., and Fleisch, H., Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells, J. Clin. Invest., 64, 206, 1979.
179. Bonjour, J. P., DeLuca, H. F., Fleisch, H., Trechsel, U., Matejowec, L. A., and Omdahl, J. L., Reversal of the EHDP inhibition of calcium absorption by 1,25-dihydroxycholecalciferol, Eur. J. Clin. Invest., 3, 44, 1973.
180. Bonjour, J. P., Trechsel, U., Fleisch, H., Schenk, R., DeLuca, H. F., and Baxter, L. A., Action of 1,25-dihydroxyvitamin D, and diphosphonate on calcium metabolism in rats, Am. J. Physiol., 229, 402, 1975.
181. Bisaz, S., Schenk, R., Kunin, A. S., Russell, R. G. G., Miihlbauer, R., and Fleisch, H. The comparative effects of vitamin D deficiency and ethane-1-hydroxy-1,1-diphosphonate administration on the histology and glycolysis of chick epiphyseal and articular cartilage, Calcif. Tissue Res., 19, 139, 1975.
182. Baxter, L. A., Canty, D. J., Bedner, G. J., Stern, L., DeLuca, H. F., Ginn, D. L., Flora, L., and Hassing, G. S., Effect of ethane-1-hydroxy-1,1-diphosphonate and vitamin D on bone mineralization, Calcif. Tissue Int., 28, 73, 1979.
183. Boris, A., Hurley, J. F., Tomal, T., Mallon, J. P., and Matuszewski, D. S., Evidence for the promotion of bone mineralization by 1,25-dihydroxy-cholecalciferol in the rat unrelated to the correction of deficiencies in serum calcium and phosphorus, J. Nutr., 108, 1899, 1978.
184. von Herrath, D., Kraft, D., and Schaefer, K., Influence of disodium dichloromethylene diphosphonate on 25-hydroxy-cholecalciferol metabolism in rats, Naunyn-Schmiedeberg’s Arch. Pharmacol., 278, 435, 1973.
185. Trechsel, U., Schenk, R., Bonjour, J. R., Russell, R. G. G., and Fleisch, H., Relation between bone mineralization, Ca absorption, and plasma Ca in phosphonate-treated rats, Am. J. Physiol., 232, E298, 1977.
186. Bonjour, J. P., Troehler, U., Preston, C, and Fleisch, H., Parathyroid hormone and renal handling of Pi: effect of dietary Pi and diphosphonates, Am. J. Physiol., 234, F487, 1978.
187. Guncaga, J., Lauffenburger, T., Lentner, C, Dambacher, M. A., Haas, H. G., Fleisch, H., and Olah, A. J., Diphosphonate treatment of Paget’s disease of bone. A correlated metabolic, calcium kinetic and morphometric study, Horm. Metab. Res., 6, 62, 1974.
188. Jowsey, J., Riggs, B., Kelly, P. J., Hossman, D. L., and Bordier, P., The treatment of osteoporosis with disodium ethane-1 -hydroxy-1,1 -diphosphonate, J. Lab. Clin. Med., 78, 574, 1971.
189. Recker, R. R., Hassing, G. S., Lau, J. R., and Saville, P. D., The hyperphosphatemic effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP9JH): renal handling of phosphorus and the renal response to parathyroid hormone, J. Lab. Clin. Med., 81, 258, 1973.
190. Russell, R. G. G., Smith, R., Preston, C, Walton, R. J., and Woods, C. G., Diphosphonates in Paget’s disease, Lancet, 7863(1), 894, 1974.
191. Smith, R., Russell, R. G. G., and Bishop, M., Diphosphonates and Paget’s disease of bone, Lancet, 7706(1), 945, 1971.
192. Citrin, D. L., Toxicity of EHDP in humans, J. Nucl. Med., 17, 417, 1976.
193. Fleisch, H., Bisaz, S., Care, A. D., Muhlbauer, R. G., and Russell, R. G. G., A review of the effects of phosphonates on calcium metabolism, Calcitonin, Proc. 2nd Int. Symp., Taylor, S., Ed., Wm. Heinemann Medical Books, London, 1970, 409.
194. Gordan, G. S. and Vaughan, C, Clinical Management of the Osteoporoses, Publishing Sciences Group, Acton, Mass., 1976.
195. Meunier, P. J., Courpron, P., Edouard, C, Alexandre, C, Bressot, C, Lips, P., and Boyce, B. F., Bone histomorphometry in osteoporotic states, Osteoporosis, Vol. 11, Barzel, U.S., Ed., Grune & Stratton, New York, 1979, 27.
196. Khairi, M. R. A. and Johnston, C. C, Exponential bone loss in postmenopausal women, Clin. Res., 26(3), 107, 1978.
197. Lockwood, D. R., Vogel, J. M., Schneider, V. S., and Hulley, S. B., Effect of the diphosphonate EHDP on bone mineral metabolism during prolonged bed rest, J. Clin. Endocrinol. Metab., 41, 533, 1975.
198. Arnstein, A. R., Blumenthal, F. S., and McCann, D. S., The effect of diphosphonate (EHDP) therapy on immobilization osteoporosis, in Proc. 55th Ann. Meet. Endocr. Soc, Chicago, 1973, A183.
199. Lauffenburger, T., Olah, A. J., Dambacher, M. A., Guncaga, J., Lentner, C., and Hass, H. G., Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget’s disease, Metab. Clin. Exp., 26, 589, 1977.
200. Heaney, R. P. and Saville, P. D., Etidronate disodium in postmenopausal osteoporosis, Clin. Pharmacol. Ther., 20, 593, 1976.
201. Gennari, C., Disodium etidronate treatment of osteoporosis, in Etidronate, Proc. 1st Int. Symp. Diphosphonate Ther. Caniggia, A., Ed., Instituto Gentili, Pisa, Italy, 1979, 133.
202. Jowsey, J., Riggs, B. L., Kelly, P. J., Hoffman, D. L., and Bordier, P., The treatment of osteoporosis with disodium ethane-1-hydroxy-1,1-diphosphonate, J. Lab. Clin. Med., 78, 574, 1971.
203. Siris, E. S., Sherman, W. H., Baquiran, D. C., Schlatterer, J. P., Osserman, E. F., and Canfeld, R. E., Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma, N. Engl. J. Med., 302, 310, 1980.
204. Douglas, D. L., Russell, R. G. G., Preston, C. J., Prenton, M. A., Duckworth, T., Kanis, J. A., Preston, F. E., and Woodhead, J. S., Effect of dichloromethylene diphosphonate in Paget’s disease of bone and in hypercalcemia due to primary hyperparathyroidism or malignant disease, Lancet, 8177(1), 1043, 1980.
205. van Breukelen, F. J. M., Bijvoet, O. L. M., and van Oosterom, A. T., Inhibition of osteolytic bone lesions by (3-amino-l-hydroxypropylidene)-l,l-biphosphonate (A.P.D.), Lancet, 8120(1), 803, 1979.
206. Chapuy, M. C., Meunier, P. J., Alexander, C. ML, and Vignon, E. P., Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases, J. Clin. Invest., 65, 1243, 1980.
207. Jacobs, T. P., Siris, E. S., Bilezikian, J. P., Baquiran, D. C., Shane, E., and Canfield, R. E., Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate, Ann. Intern. Med., 94, 312, 1981.
208. Cohen, A. I., Koeller, J., Davis, T. E., and Citrin, D. L., Intravenous dichloromethylene diphosphonate in cancer associated hypercalcemia-A phase I/II Evaluation. Cancer Treat. Rep., 65, 651, 1981.
209. Jung, A, Bornand, J., van Ouwenaller, C, Chantraine, A., and Donath, A., Effects of diphosphonates on tumor-induced osteolysis in animals and in humans, in VII Int. Conf. on Calcium Regulating Hormones, Talmage, R. V., Matthews, J. L., and Cohn, D., Eds., Excerpta Medica, Amsterdam, 1980, 1103.
210. Bassett, C. A. L., Donath, A., Magagno, F., Preisig, R., Fleisch, H., and Francis, M. D., Diphosphonates in the treatment of Myositis Ossificans, Lancet, 7625(2), 845, 1969.
211. Russell, R. G. G., Smith, R., Bishop, M. C, Price, D. A., and Squire, C. M., Treatment of Myositis Ossificans Progressiva with a diphosphonate, Lancet, 7740(1), 10, 1972.
212. Weiss, I. W., Fisher, L., and Phang, J. M., Diphosphonate therapy in a patient with Myositia Ossificans Progressiva, Arm. Intern. Med., 74, 933, 1971.
213. Geho, W. B. and Whiteside, J. A., Experience with disodium etidronate in diseases of ectopic calcification, in Clinical Aspects of Metabolic Bone Disease, Frame, B., Parfitt, A., and Duncan, H., Eds., International Congress Series, Amsterdam, 1973, 506.
214. Cram, R. L., Barrmada, R., Geho, W. B., and Ray, R. D., Diphosphonate treatment of calcinosis universalis, V. Engl. J. Med., 285, 1012, 1971.
215. Barry, H. C, Paget’s Disease of Bone, Practitioner, 210, 340, 1973.
216. Nagant de Deuxchaisnes, C. and Krane, S. M, Paget’s disease of bone. Clinical and metabolic observations, Medicine, 43, 233, 1964.
217. Altman, R. D., Johnston, C. C, Khari, M. R. A., Wellman, H., Serafini, A. N., and Sankey, R. R., Influence of disodium etidronate on clinical and laboratory manifestations of Paget’s disease of bone (Osteitis deformans), N. Engl. J. Med., 289, 1379, 1973.
218. Canfield, R., Rosner, W., and Skinner, J., McWhorter, J., Resnick, L., Feldman, F., Kammerman, S., Ryan, K., Kunegonis, M., and Bohne, W., Diphosphonate therapy of Paget’s disease of bone, J. Clin. Endocrinol. Metab., 44, 96, 1977.
219. Khairi, M. R. A., Altman, R. D., DeRosa, G. P., Zimmerman, J., Schenk, R. K., and Johnston, C. C, Sodium etidronate in the treatment of Paget’s disease of bone, Ann. Intern. Med., 87, 656, 1977.
220. Meunier, P., Chapuy, M. C, Courpron, P., Vignon, E., Edouard, C, and Bernard, J., Effets cliniques, biologiques et histologiques de l’ethane-1-hydroxy-1,1-diphosphonate (EHDP) dans la maladie de Paget, Rev. Rhum., 42, 699, 1975.
221. Hosking, D. J., Bijvoet, O. L. M., van Aken, J., and Will, E. J., Paget’s bone disease treated with diphosphonate and calcitonin, Lancet, 7960(1), 615, 1976.
222. Nagant de Deuxchaisnes, C, Rombouts-Lindemans, C, Huaux, J. P., Devogelaer, J. P., Maglhem, J., and Maldague, B., Roentgenologic evaluation of the action of the diphosphonate EHDP and of combined therapy (EHDP and Calcitonin) in Paget’s disease of bone, in Molecular Endocrinology, Macintyre, I. and Szelke, M., Eds., Elsevier/North Holland and Biomedical Press, Amsterdam, 1979, 405.
223. Finerman, G. A. M., Gonick, H. C, Smith, R. K., and Mayfield, J. M., Diphosphonate treatment of Paget’s disease, Clin. Orthop. Relat., Res., 120, 115, 1976.
224. Funcaga, J., Lauffenburger, T., Lentner, C, Darnbacher, M. A., Haas, H. G., Fleisch, H., and Oleh, A. J., Diphosphonate treatment of Paget’s disease of bone, Harm. Metab. Res., 6, 62, 1974.
225. Khairi, M. R. A., Meunier, P., Edouard, C., Courpron, P., Bernard, J., Derosa, G. P., and Johnston, C. C., Jr., Quantitative bone histology in Paget’s disease of bone: influence of sodium etidronate (EHDP) therapy, Calcif. Tissue Res., 22, 355, 1977.
226. Johnston, C. C., Khairi, M. R. A., and Meunier, P. J., Use of Etidronate (EHDP) in Paget’s disease of bone, Arthritis Rheum., 23, 1172, 1980.
227. Siris, E. S., Thomas, P. J., and Canfield, R. E., Paget’s disease of bone, Bull. N. Y. Acad. Med., 56(3), 285, 1980.
228. Murphy, W. A., Whyte, M. P., and Haddad, J. G., Healing of lytic Paget bone disease with diphosphonate therapy, Diag. Radiol., 134, 635, 1980.
229. Frijlink, W. B., Bijvoet, O. L. M., te Velde, J., and Heynen, G., Treatment of Paget’s disease with (3-amino-l-hydroxypropylidene)-l ,1-bisphosphate (APD), Lancet, 1(8120), 799, 1979.
230. Meunier, P. J., Chapuy, M. C, Alexandre, C, Bressot, C, Edouard, C, Vignon, E., Mathieu, L., and Trechsel, U., Effects of disodium dichloromethylene diphosphonate on Paget’s disease of bone, Lancet, 8141(2), 489, 1979.
231. Alexandre, C. M., Matthews, J. L., Meunier, P. J., Martin, J. H., and Petit, H., Ultrastructural aspects of osteoclasts and osteoblasts in Paget’s disease of bone treated with dichloromethylene disphos-phonate (C12MDP), in VII Int. Conf. on Calcium Regulating Hormones, Talmage, R. V., Matthews, J. L., and Cohn, D., Eds., Excerpta Medica, Amsterdam, 1980, 120.
232. Mills, B. G. and Singer, F. R., Nuclear inclusions in Paget’s disease of bone, Science, 194, 201, 1976.
233. Rebel, A., Malkani, K., Basle, M., and Bregeon, C, Nuclear inclusions in osteoclasts in Paget’s bone disease, Calcif. Tissue Res., 21(Suppl.), 113, 1976.
234. Ditzel, J., Oxygen transport impairment in diabetics, Diabetes, 25, (Suppl. 2) 832, 1976.
235. Ditzel, J., Hau, C, and Daugaard, N., Effect of the diphosphonate ethane-1-hydroxy-1,1-diphosphonate (EHDP) on hemoglobin oxygen affinity of diabetic and healthy subjects, Microvasc. Res., 13, 355, 1977.
236. Ditzel, J., Hau, C, and Daugaard, N., Effects of the diphosphonate EHDP on plasma inorganic phosphate and hemoglobin oxygen affinity of diabetic and healthy subjects, in Advances in Experimental Medicine and Biology, Massry, S. G. and Ritz, E., Eds., Plenum Press, New York, 1977, 423.
237. Francis, M. D., Slough, C. L., Tofe, A. J., and Silberstein, E. B., Factors affecting uptake and retention of technetium-99m-diphosphonate and 99m-pertechnetate in osseous, connective, and soft tissues, Calcif. Tissue Res., 20, .303, 1976.
238. Steigman, J., Chin, E. V., and Solomon, N. A., Scintiphotos in rabbits made with Tc-99m preparations reduced by electrolysis and by SnClj, J. Nucl. Med., 20, 766, 1979.
239. Tofe, A. J. and Francis, M. D., Optimization of the ratio of stannous tin: ethane-1-hydroxy-1,1-diphosphonate for bone scanning with "“Tc-pertechnetate, J. Nucl. Med., 15, 69, 1974.
240. Deutsch, E., Libson, K., Becker, C. B., Francis, M. D., Tofe, A. J., Ferguson, D. L., and McCreary, L. D., Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion, J. Nucl. Med., 21, 859, 1980.
241. Subramanian, G., McAfee, J. G., Blair, R. J., Kallfelz, F. A., and Thomas, F. D., Technetium-99m-methylene diphosphonate - a superior agent for skeletal imaging. Comparison with other technetium complexes, J. Nucl. Med., 16, 744, 1975.
242. Francis, M. D., Ferguson, D. L., Tofe, A. J., Bevan, J. A., and Michaels, S. E., Comparative evaluation of three diphosphonates: in vitro adsorption (C-14 labelled) and in vivo osteogenic uptake (Tc-99m complexed), J. Nucl. Med., 21, 1185, 1980.
243. Davis, M. A. and Jones, A. G., Comparison of “mTc-labeled phosphate and phosphonate agents for skeletal imaging, Semin. Nucl. Med., 6, 19, 1976.
244. Jones, A. G., Francis, M. D., and Davis, M. A., Bone scanning: radionuclidic reaction mechanisms, Semin. Nucl. Med., 6, 3, 1976.
245. Tofe, A. J., Francis, M. D., and Harvey, W. J., Correlation of neoplasms with incidence and localization of skeletal metastases: an analysis of 1,355 diphosphonate bone scans, J. Nucl. Med., 16, 986, 1975.
246. Handmaker, H. and Leonards, R., The bone scan in inflammatory osseous disease, Semin. Nucl. Med., 6, 95, 1976.
247. Fogelman, L, Tofe, A. J., and Francis, M. D., Whole body retention: comparison of three diphosphonates, J. Nucl. Med., 22, P78, 1981.
248. Fogelman, L, Citrin, D. L., McKillop, J. H., Turner, J. G., Bissent, R. G., and Greig, W. R., A clinical comparison of Tc-99m HEDP and Tc-99m MDP in the detection of bone metastases: concise communication, J. Nucl. Med., 20, 98, 1979.
249. Arnold, J. S., Barnes, W. E., and Khedkar, N., Kinetic studies of a new and superior Tc-99m diphosphonate bone imaging agent, J. Nucl. Med., 20, 653, 1979.